Pieper Steven bought XERS
March 5, 2026 · Form 4 insider transaction
Pieper Steven bought 27,891 shares of Xeris Biopharma Holdings, Inc. at $4.09 per share, a transaction worth $114.1K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
27,891
Price
$4.09
Total value
$114.1K
InsiderPieper Steven
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 5, 2026
Filing dateMarch 5, 2026
Shares owned after1,394,904
OwnershipDirect
10b5-1 planNo
AmendedNo